Pricing Log in Create free account
Friday 6 November 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Revenue
−10.5%
EPS
+48.5%
Free cash flow
−31.6%
Total debt
−23.8%

Quarter to September 2026, against a year earlier

212.21 1.34 −0.63%
Market cap
$58.2B
P/E
51.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
6/9
Altman Z
n/a
Beneish M
−2.76
Dividend safety
51/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Becton, Dickinson and Company (BDX) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 7 added · 10 removed · 54 modified
P2I1A: no material changes, the filing says
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 19, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K May 29, 2026 7.01 Regulation FD disclosure
8-K May 20, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K May 11, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 19 added · 17 removed · 74 modified
P2I1A: no material changes, the filing says
8-K/A Oct 9, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 28, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Apr 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 2, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 25, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 10, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Dec 31, 2025
8-K Feb 9, 2026 1.01 Entry into a material definitive agreement; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 9, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 30, 2026 3.02 Unregistered sales of equity securities; 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Feb 5, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 27, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
8-K Dec 30, 2025 5.04 Suspension of trading under employee benefit plans
8-K/A Nov 17, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-K Sep 30, 2025 1: 7 added · 12 removed · 33 modified
1A: 18 added · 13 removed · 57 modified
7: 36 added · 38 removed · 85 modified
8-K Nov 17, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 9, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 16, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: 7 added · 6 removed · 60 modified
P2I1A: no comparison — the Item could not be matched reliably
8-K Aug 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025 P1I2: no comparison — the earlier filing's text is no longer kept
P2I1A: no comparison — the earlier filing's text is no longer kept
8-K May 1, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Dec 31, 2024
8-K Feb 5, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Sep 30, 2024
8-K Nov 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 9, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.